Researchers are excitedly focused on retatrutide, a promising medication from Eli Lilly, as a possible breakthrough in weight management. Distinct from many earlier approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, hormones that affect satiety and blood glucose re… Read More